Cyclic di-AMP regulates genome stability and drug resistance in Mycobacterium through RecA-dependent and RecA-independent recombination
2024

Cyclic di-AMP and its Role in DNA Repair and Drug Resistance in Mycobacterium

publication 10 minutes Evidence: high

Author Information

Author(s): Mudgal Sudhanshu, Goyal Nisha, Kasi Manikandan, Saginela Rahul, Singhal Anusha, Nandi Soumyadeep, Mahmud A K M Firoj, Muniyappa Kalappa, Sinha Krishna Murari, Bahar Ivet

Primary Institution: Amity Institute of Biotechnology, Amity University Haryana

Hypothesis

Cyclic di-AMP regulates genome stability and drug resistance in Mycobacterium through RecA-dependent and RecA-independent recombination.

Conclusion

The absence of cyclic di-AMP leads to increased DNA recombination and higher drug resistance in Mycobacterium smegmatis.

Supporting Evidence

  • Cells lacking cyclic di-AMP showed increased levels of homology-directed repair and higher mutation rates.
  • The absence of cyclic di-AMP resulted in a two-fold increase in rifampicin-resistant colonies.
  • Cyclic di-AMP inhibits RecA-mediated self-cleavage of LexA repressor, enhancing the SOS response.
  • Complementation with wild-type RecA restored drug resistance in ΔrecA mutants.

Takeaway

Cyclic di-AMP helps bacteria fix their DNA and stay healthy; without it, they can get more mutations and become resistant to drugs.

Methodology

The study used genetic assays to analyze DNA repair pathways in Mycobacterium smegmatis, focusing on the effects of cyclic di-AMP on RecA-mediated and RecA-independent homologous recombination.

Limitations

The precise mechanisms by which cyclic di-AMP regulates RecA-independent pathways remain unclear.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1093/pnasnexus/pgae555

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication